Orlistat

Alona Crowder, Pharm.D., Reza Alavi, M.D.
Orlistat is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Xenical (Prescription Strength): Obesity management including weight loss and weight maintenance in patients with a body mass index (BMI) ≥ 30 kg/m2 OR ≥ 27 kg/m2 in the presence of other risk factors (eg, hypertension, diabetes, dyslipidemia).
  • Alli (OTC Strength): Obesity management in overweight adults (18 years and older) when used along with a reduced-calorie and low-fat diet

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: November 30, 2015

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Orlistat ID - 547107 A1 - Crowder,Alona,Pharm.D. AU - Alavi,Reza,M.D. Y1 - 2015/11/30/ PB - Johns Hopkins Diabetes Guide UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547107/all/Orlistat ER -